Gongwin Biopharm Co., Ltd.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Mar 12, 2027
- 1 fee due Aug 4, 2027The maintenance fee for Topical formulation and method for preventing or treating acne (US 10,548,862) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 21, 2026
- Oct 6 US 12,751,936 Benzenesulfonamide Derivatives and Method for Treating Cancer
- Sep 22 US 12,740,952 Benzenesulfonamide Derivatives and Method for Modulating Lipid Raft
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,752,118 | Method for Treating Melanoma In force · High confidence | In force | High confidence | |
| US 12,751,936 | Benzenesulfonamide Derivatives and Method for Treating Cancer In force · Medium confidence | In force | Medium confidence | |
| US 12,144,789 | Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth In force · USPTO record | In force | USPTO record | |
| US 10,548,862 | Topical formulation and method for preventing or treating acne In force · USPTO record | In force | USPTO record | |
| US 12,740,952 | Benzenesulfonamide Derivatives and Method for Modulating Lipid Raft In force · High confidence | In force | High confidence | |
| US 11,752,160 | Method for Reducing Fat by Administering Benzenesulfonamide Compositions In force · High confidence | In force | High confidence | |
| US 12,109,210 | Methods for Treating Mast Cell Tumors In force · High confidence | In force | High confidence | |
| US 12,023,310 | Method for treating peripheral nerve sheath tumor In force · USPTO record | In force | USPTO record | |
| US 12,409,158 | Combination Therapy for Treating Cancer In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 4 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 no status recorded